XR Securities’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-492
Closed -$225K 559
2021
Q1
$225K Sell
492
-1,256
-72% -$599K 0.01% 193
2020
Q4
$814K Buy
+1,748
New +$820K 0.06% 54
2020
Q1
Sell
-751
Closed -$244K 298
2019
Q4
$244K Buy
+751
New +$228K 0.03% 111
2019
Q2
Sell
-1,768
Closed -$484K 363
2019
Q1
$484K Buy
1,768
+94
+6% +$23.4K 0.06% 82
2018
Q4
$375K Buy
+1,674
New +$393K 0.16% 85

Other funds holding TMO

XR Securities's TMO Position: Q2 2021 in Review

XR Securities sold out of Thermo Fisher Scientific (TMO) in Q2 2021, closing a stake of 492 shares — an estimated $225K sold.

XR Securities first reported a position in TMO in Q4 2018 and held it in 5 quarters. The position peaked at $814K in Q4 2020. 2,075 funds tracked by Wall St. Rank hold TMO as of Q2 2021.

  • XR Securities reported no remaining Thermo Fisher Scientific position as of Q2 2021 after selling out during the quarter.
  • XR Securities sold 492 Thermo Fisher Scientific shares in Q2 2021, an estimated $225K.
  • XR Securities first reported a position in Thermo Fisher Scientific in Q4 2018 and held it in 5 quarters.
  • XR Securities's Thermo Fisher Scientific position peaked at $814K in Q4 2020.
  • 2,075 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2021.

Based on XR Securities's 13F filing for Q2 2021, filed 26 Jul 2021.